Recurrence of crescentic IgA nephropathy after renal transplantation
- 75 Downloads
IgA nephropathy (IgAN) is one of the most common recurrent glomerulonephritis after renal transplantation. Rarely, it is accompanied with the presence of crescents that leads to rapid deterioration of renal function and graft loss. We present a 54-year-old patient with IgAN that received a cadaveric kidney allograft, but developed biopsy proven recurrent IgAN 7 months after renal transplantation. He was treated with intravenous steroids and angiotensin-converting enzyme inhibitor and remission was achieved. 4 years later, he presented again with heavy proteinuria, hematuria and deterioration of renal function. Allograft biopsy revealed recurrent IgAN with crescents, which was successfully treated with pulse intravenous steroids and six monthly doses of intravenous cyclophosphamide. This regime resulted in long-term sustained remission with a stable functioning graft 3 years later. Although it is not an established treatment as in native kidneys, intravenous cyclophosphamide should probably be considered in kidney transplants with potentially reversible recurrent crescentic IgAN.
KeywordsIgA nephropathy Renal transplantation Recurrent glomerulonephritis Crescents
Compliance with ethical standards
Conflict of interest
The authors have declared that no Conflict of interest exists.
Research involving human participants and/or animals
This article does not contain any studies with human participants or animals performed by any of the authors.
Informed consent was obtained from all individual participants included in the study. Additional informed consent was obtained from all individual participants for whom identifying information is included in this article.
- 14.Park SB, Joo I, Park KA, Cho WH, Park CH, Kim SP, et al. Rapidly progressive glomerulonephritis in a renal transplant with recurrent IgA nephropathy. Transpl Proc. 1996;28(3):1529–30.Google Scholar
- 17.Mousson C, Charon-Barra C, Funes de la Vega M, Tanter Y, Justrabo E, Martin L, et al. Recurrence of IgA nephropathy with crescents in kidney transplants. Transpl Proc. 2007;39(8):2595–6. https://doi.org/10.1016/j.transproceed.2007.08.025.CrossRefGoogle Scholar
- 18.Gopalakrishnan N, Murugananth S, Dineshkumar T, Dhanapriya J, Sakthirajan R, Balasubramaniyan T. Two consecutive recurrences of crescentic immunoglobulin a nephropathy in a renal transplant recipient. Indian J Nephrol. 2016;26(5):376–8. https://doi.org/10.4103/0971-4065.169565.CrossRefPubMedPubMedCentralGoogle Scholar
- 19.Herzog AL, Wanner C, Amann K, Lopau K. First treatment of relapsing rapidly progressive IgA nephropathy With Eculizumab after living kidney donation: a case report. Transpl Proc. 2017;49(7):1574–7. https://doi.org/10.1016/j.transproceed.2017.02.044.CrossRefPubMedGoogle Scholar
- 20.Katsumata H, Yamamoto I, Komatsuzaki Y, Kawabe M, Okabayashi Y, Yamakawa T, et al. Successful treatment of recurrent immunoglobulin a nephropathy using steroid pulse therapy plus tonsillectomy 10 years after kidney transplantation: a case presentation. BMC Nephrol. 2018;19(1):64. https://doi.org/10.1186/s12882-018-0858-9.CrossRefPubMedPubMedCentralGoogle Scholar